The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: -0.25 (-3.45%)
Spread: 0.50 (7.407%)
Open: 7.50
High: 7.25
Low: 7.00
Prev. Close: 7.25
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Ashtead Rises After Strong First Quarter

Tue, 11th Sep 2018 10:41

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Ashtead Group, up 2.5%. The equipment rentals firm said it will increase and extend its current share buyback programme following profit growth in the first quarter of current financial year. Ashtead said revenue in the three months to the end of July rose 22% to GBP1.05 billion from GBP880.1 million reported a year earlier, pushing pretax profit up 23% to GBP274.4 million from GBP228.9 million. Ashtead said the results were driven by strong organic growth, supplemented by bolt-on acquisitions, most notably the purchase of bulldozers retailer CRS in August last year. During the quarter, the company said it bought back 4.1 million shares, totalling GBP94 million. To date, Ashtead has spent GBP300 million under the share buyback programme announced in December last year. The company said it intends to increase and extend its buyback plans, increasing the spend to GBP125 million per quarter and resulting in a total outlay of GBP675 million in financial 2019. The company also revealed plans for a new share buyback programme in financial 2020, with an anticipated spend of at least GBP500 million.----------FTSE 100 - LOSERS----------BHP Billiton, down 1.5%. The Anglo-Australian miner was cut to Hold from Buy by Deutsche Bank. ----------FTSE 250 - WINNERS----------JD Wetherspoon, up 2.2%. Berenberg raised the pub chain to Buy from Hold.----------Hilton Food Group, up 2.1%. The food packaging company said it is confident in the company's future growth after posting an increase in profit and revenue for the first half of the year. For the 28 weeks to July 15, the firm posted 14% rise in pretax profit to GBP21.0 million from GBP18.4 million a year ago. This was as revenue jumped by 25% to GBP863.6 million from GBP690.7 million. Earnings before interest, taxes, depreciation and amortisation increased to GBP35.5 million from GBP29.6 million in the comparative year ago period, "broadly" reflecting the new Seachill, business which was acquired in November 2017 and has "delivered on expectations", Hilton Food said. The company upped its interim dividend by 12% to 5.6 pence from 5.0p a year prior.----------Sanne Group, up 2.0%. The fund administrator said its profit for the first half of 2018 came in lower year-on-year due to the integration expenses associated with IFS Group. Sanne said pretax profit declined 13% to GBP10.9 million in the six months to June 30 compared to GBP12.5 million reported for the same period a year ago, despite revenue jumping by 17% to GBP65.9 million from GBP56.3 million. However, the company said it saw a good organic growth across all of its divisions, supported by acquisition of alternative investment fund LIS in February, which contributed for five months of the period. Sanne said this acquisition provided a number of good cross-selling opportunities and exposure to a new range of institutional real estate fund managers. As a result, revenue in the Europe, the Middle East & Africa Alternatives division rose by 41% to GBP32.7 million from GBP23.1 million.----------FTSE 250 - LOSERS----------Cairn Energy, down 5.0%. The oil and gas explorer said it swung to a loss in the first half of its financial year on the back of constrained production and downtime and fair value losses. For the six months to June 30, the company posted a pretax loss of USD602.9 million, compared to a USD77.7 million profit in the half-year period last year. This was due to the company swinging to a USD319.4 million loss on the fair value of its financial assets compared to a USD200.5 million profit the year prior. The swing to a loss on financial assets was mainly caused by Cairn's 3% stake in Vedanta Ltd. Cairn recognized a USD230.8 million loss on the holding, after it was sold on the demand of the Indian tax authority and USD231 million in proceeds from the sale seized. Cairn said it remains confident of its legal position in the tax dispute.----------Elementis, down 3.9% at 243.00 pence. The speciality chemicals company said it will now pay USD553 million to acquire Dutch industrial talc mineral additive firm Mondo Minerals Holding instead of USD600 million agreed previously. The company, which was forced to reconsider the Mondo deal due to shareholder concerns, will pay USD500 million in cash to Advent Mondo (Luxembourg) to buy Mondo plus USD53.0 million in earn-out payments upon subject to the achievement of certain performance targets by Mondo. It intends to fund the deal via a USD230 million rights issue of shares and by utilising a new USD775.0 million term and revolving credit facility. The right issue will be on the basis of 1 new ordinary share at 152.0 pence per share for every 4 existing shares, and Elementis will offer up to 116.0 million new shares.----------OTHER MAIN MARKET AND AIM - WINNERS----------Produce Investments, up 32% at 187.20p. The fresh potato and daffodil producer said it reached an agreement with Promethean Investments for acquisition of the company by a Promethean vehicle April 1983 Bidco. The offer of 193 pence per share in cash values Produce as a whole at GBP53.0 million. The 193p offer is a 35% premium on the company's closing price of 143p on Monday. The Promethean offer includes a partial share and loan note alternative under which Produce shareholders will be able to elect to receive 98.43p in cash and one unit. Each unit comprises one April 1983 share and one April loan note. Produce's board said it "considers the terms of the offer to be fair and reasonable". ----------IXICO, up 24%. The brain medicine developer said it inked a new contract worth GBP9.1 million with an unnamed "top-10 global pharmaceutical company". The contract which lasts over a four-year term is for the provision of IXICO's technology-enabled imaging services in support of a study of Huntington's disease, a genetic neurodegenerative disorder affecting movement, cognition and behaviour. As part of the study, IXICO will optimise, standardise and collect magnetic resonance imaging data from specialist imaging centres. Afterwards, the company's "data science expertise and artificial intelligence software algorithms will be applied to provide insights into brain cellular microstructure and neuronal connectivity to support the evaluation of drug safety and efficacy", IXICO explained.----------OTHER MAIN MARKET AND AIM - LOSERS----------Haydale Graphene, down 14%. The graphene materials firm said it is holding talks with the Amiblu Technology research team to discuss "the next steps" after a disappointing trial to develop a new pipeline product. The results of a trial in March for Amiblu Technology, formerly Flowtite Technology, "did not show the improvements Haydale had hoped for", the company explained. Amiblu Technology is the glass fibre reinforced plastic pipe technology and research and development centre of the Saudi Arabian Amiantit Co with which Haydale partnered to develop glass fibre reinforced plastic products in May 2016.----------
More News
19 Oct 2020 09:38

Ixico FY revenues grow by more than a quarter

(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were up year-on-year as its data analytics service strategy continued to drive growth.

Read more
16 Oct 2020 16:23

Ixico enters deal with NUY Langone Health for drug trial

(Sharecast News) - Data analytics company Ixico has entered into an agreement with NYU Langone Health to support a trial to determine if the immunosuppressant drug Sirolimus, approved by the FDA to prevent organ transplant rejection and for the treatment of a rare and progressive lung disease called lymphangioleiomyomatosis, is also able to slow the progression of disease in people with multiple system atrophy (MSA).

Read more
24 Sep 2020 16:30

Ixico joins Friedreich's Ataxia research consortium

(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).

Read more
24 Sep 2020 16:30

Ixico joins Friedreich's Ataxia research consortium

(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).

Read more
21 Sep 2020 13:35

Ixico selected to support Alzheimer's trial

(Sharecast News) - Data analytics company Ixico has been selected by the Global Alzheimer's Platform Foundation (GAP) to support its planned 'Bio-Hermes' trial.

Read more
24 Aug 2020 09:18

Ixico FY revenues, underlying earnings ahead of forecasts

(Sharecast News) - Data analytics company Ixico said on Monday that it had recorded "stronger-than-anticipated" second-half revenues and underlying earnings despite Covid-19.

Read more
24 Jun 2020 09:41

Ixico sees only 'modest' impact on trading from Covid-19

(Sharecast News) - Data analytics company Ixico said on Wednesday that Covid-19 had only had a "modest" impact on trading and stated it expects to maintain double-digit revenue growth in 2021.

Read more
20 Apr 2020 08:50

Ixico in 'robust' position to handle short-term Covid-19 headwinds

(Sharecast News) - Data analytics firm Ixico said on Monday that it was in a "robust" position to handle short-term headwinds stemming from the Covid-19 pandemic and associated government measures.

Read more
14 Apr 2020 09:32

Ixico inks ?10.5m contract, trading impacted by Covid-19 in 'multiple ways'

(Sharecast News) - Neuroscience data analytics firm Ixico has inked a £10.5m contract for a late-phase open-label study into Huntington's disease, but warned that the Covid-19 pandemic had affected it in "multiple ways".

Read more
3 Feb 2020 14:05

Ixico joins Alzheimer's disease research initiative

(Sharecast News) - Artificial intelligence data analytics company Ixico announced funding support for the Alzheimer's Disease Neuroimaging Initiative (ADNI) on Monday, with two of its scientists to join the ADNI-Private Partner Scientific Board (PPSB).

Read more
23 Jan 2020 16:10

Director dealings: Ixico CEO ups stake

(Sharecast News) - Ixico revealed on Thursday that chief executive Giulio Cerroni had purchased 24,800 ordinary shares in the British clinical research firm.

Read more
23 Dec 2019 15:04

Ixico announces extensions to two studies

(Sharecast News) - Data analytics company Ixico announced a £1.8m extension to a phase 3 study in Huntington's Disease on Monday, which it had previously announced in September 2018.

Read more
28 Oct 2019 13:15

Ixico secures three new contracts, appoints chief business officer

(Sharecast News) - AI data analytics company Ixico said on Monday that it had secured three new contracts and appointed a chief business officer.

Read more
15 Oct 2019 15:33

Ixico flags better-than-expected performance for full-year

(Sharecast News) - Artificial intelligence data analytics company Ixico updated the market on its trading for the year ended 30 September on Tuesday, saying it expected its first full year of positive EBITDA since listing.

Read more
15 Oct 2019 12:30

IXICO Predicts Maiden Positive Ebitda In Financial 2019

IXICO Predicts Maiden Positive Ebitda In Financial 2019

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.